52
Participants
Start Date
July 31, 2011
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
AAB-003 (PF-05236812)
0.5 mg/kg AAB-003, IV
AAB-003 (PF-05236812)
1 mg/kg AAB-003, IV
AAB-003 (PF-05236812)
2 mg/kg AAB-003, IV
AAB-003 (PF-05236812)
4 mg/kg AAB-003, IV
AAB-003 (PF-05236812)
8 mg/kg AAB-003, IV
Foers Medical Arts Pharmacy, Bethesda
CBH Health, LLC, Rockville
Atlanta Center for Medical Research, Atlanta
MD Clinical, Hallandale
Munroe Regional Medical Center, Ocala
Renstar Medical Research, Ocala
Trinity Care Solutions, Ocala
Advanced Imaging of Ocala, Ocala
Borgess Medical Center, Kalamazoo
Borgess Research Institute, Kalamazoo
KNI Southwest Michigan Imaging Center, LLC, Kalamazoo
DePaul Health Center-MRI Department, St Louis
Millennium Psychiatric Associates, LLC, Creve Coeur
Konkuk University Medical Center, Department of Neurology, Seoul
Samsung Medical Center, Department of Neurology, Seoul
Memory Enhancement Center of America, Inc., Eatontown
Central Jersey Radiology, Oakhurst
Seoul National University Hospital, Department Neurology, Seongnam-si
Inha University Hospital, Department of Neurology, Incheon
Korea University Anam Hospital IRB, Seoul
ASAN Medical Center, Seoul
Lead Sponsor
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
INDUSTRY
Pfizer
INDUSTRY